PRELUDE
PreludeDx was founded with the goal of providing better decision-making tools to breast cancer patients and physicians. Founded in 2009 with technology licensed from the University of California San Francisco, PreludeDx has focused on developing breast cancer tools that will impact a patient’s treatment decision. Their mission is to provide tools that improve patient outcomes in breast cancer and reduce the overall cost burden to the healthcare system.
PRELUDE
Industry:
Biotechnology Health Care Life Science Pharmaceutical
Founded:
2009-01-01
Address:
Laguna Hills, California, United States
Country:
United States
Website Url:
http://www.preludedx.com
Total Employee:
11+
Status:
Active
Contact:
(888) 211-3247
Email Addresses:
[email protected]
Total Funding:
22.15 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro WordPress Font Awesome Sitelinks Search Box Yoast WordPress SEO Plugin Yoast Plugins Yoast SEO Premium GStatic Google Static Content
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Apic Bio
Apic Bio is a gene therapy company that develops treatment options for rare, undertreated neurological and liver diseases.
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Atlas Venture
Atlas Venture creates and invests in biotech startup companies with seed and early stage venture investments.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Current Advisors List
Current Employees Featured
Investors List
Evidity Health Capital
Evidity Health Capital investment in Venture Round - Prelude
genesiscare
genesiscare investment in Corporate Round - Prelude
Key Employee Changes
Official Site Inspections
http://www.preludedx.com Semrush global rank: 6.83 M Semrush visits lastest month: 990
- Host name: 199.16.173.131
- IP address: 199.16.173.131
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Prelude"
Your Biology, Your Decision | PreludeDx DCIS test
PreludeDx delivers actionable tools to manage early stage breast cancer with the DCIS test that enables personalized treatment.See details»
Prelude - Crunchbase Company Profile & Funding
PreludeDx was founded with the goal of providing better decision-making tools to breast cancer patients and physicians. Founded in 2009 with technology licensed from the University of …See details»
Physicians - DCISionRT Info - PreludeDx
DCISionRT The Test for DCISSee details»
PreludeDx - LinkedIn
PreludeDx was founded to deliver actionable tools to manage early stage breast cancer. PreludeDx's first diagnostic test, DCISionRT is the result of over a decade of research …See details»
PreludeDx Company Profile 2025: Valuation, Funding
PreludeDx General Information Description. Developer of decision-making actionable tools intended to manage early-stage breast cancer. The company's tools improve patient outcomes in breast cancer and reduce the overall cost …See details»
FDA grants breakthrough designation to PreludeDx’s DCIS test
22 minutes ago Founded in 2009, PreludeDx is a company specialising in breast cancer diagnostics. "FDA grants breakthrough designation to PreludeDx’s DCIS test" was originally …See details»
PreludeDx Company Profile - Office Locations, Competitors ... - Craft
PreludeDx is a company that develops tools to manage early-stage breast cancer. It offers a test called DCISionRT2, which allows patients and their physicians to choose a treatment …See details»
PreludeDx CEO and Key Executive Team | Craft.co
PreludeDx's President & CEO, Director is Daniel Forche. Other executives include Andrew Wade, CFO; Troy Bremer, CSO and 7 others. See the full leadership team at Craft.See details»
PreludeDx™ Closes $20 Million in Funding to Advance Growth …
Mar 22, 2022 Evidity Health Capital to Join Board of Directors. LAGUNA HILLS, Calif., March 22, 2022 /PRNewswire/-- Prelude Corporation (PreludeDxâ„¢), a leader in molecular diagnostics …See details»
PreludeDx Receives FDA Breakthrough Device Designation for …
22 hours ago Prelude Corporation (PreludeDx®), a leader in precision diagnostics for early-stage breast cancer, announced today that the U.S. Food and Drug Administration (FDA) …See details»
PreludeDx™ Announces Novel Test for Predicting Radiation …
Mar 14, 2024 Prelude Corporation (PreludeDxâ„¢), a leader in precision diagnostics, has unveiled data from an analysis of over 700 early-stage invasive breast cancer patients for AidaBreastâ„¢ …See details»
Contact Us - Patient - PreludeDx
Contact PreludeDx for patient inquiries and support regarding their services and tests.See details»
PreludeDX - Products, Competitors, Financials, Employees, …
PreludeDx Announces Groundbreaking Study Results on HER2-Positive DCIS Patients. Oct 2, 2024. News provided by Share this article Share toX LAGUNA HILLS, Calif., Oct. 2, 2024 …See details»
What is PreludeDx? Company Culture, Mission, Values
See what employees say it's like to work at PreludeDx. Salaries, reviews, and more - all posted by employees working at PreludeDx.See details»
PreludeDx - Overview, News & Similar companies | ZoomInfo.com
PreludeDx is a leading personalized breast cancer diagnostics company dedicated to serving breast cancer patients and physicians worldwide. Founded in 2009 with technology licensed …See details»
PreludeDx Appoints Edwin C. Hendrick Chief Commercial Officer
PreludeDx Appoints Edwin C. Hendrick Chief Commercial Officer LAGUNA HILLS, Calif., Feb. 12, 2020 /PRNewswire/-- Prelude Corporation (PreludeDxä), a ... "We are thrilled to welcome …See details»
Home - Prelude Therapeutics
Dec 11, 2024 Prelude Therapeutics is a leading precision oncology company developing innovative medicines in areas of high unmet need for cancer patients. Our pipeline is …See details»
PreludeDx Receives FDA Breakthrough Device Designation for …
22 hours ago DCISionRT, developed by PreludeDx on technology licensed from the University of California San Francisco, and built on research that began with funding from the National …See details»
PreludeDx Announces Groundbreaking Study Results on HER2 …
Oct 2, 2024 Prelude Corporation (PreludeDx®), a leader in precision diagnostics for early-stage breast cancer, today announced results of a cutting-edge study in Clinical Breast Cancer. The …See details»
Will I get a bill for the PreludeDx test? | PreludeDx
Due to health insurance plan requirements, some patients may receive a bill from PreludeDx for a portion of the test cost, which could include a portion of the annual deductible, required co-pay …See details»